- Home
- KE vs SANA Comparison
KE vs SANA Comparison
Compare KE & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KE
- SANA
- Stock Information
- Founded
- KE 1961
- SANA 2018
- Country
- KE United States
- SANA United States
- Employees
- KE N/A
- SANA N/A
- Industry
- KE Electrical Products
- SANA Medicinal Chemicals and Botanical Products
- Sector
- KE Technology
- SANA Health Care
- Exchange
- KE Nasdaq
- SANA Nasdaq
- Market Cap
- KE 467.2M
- SANA 522.4M
- IPO Year
- KE N/A
- SANA 2021
- Fundamental
- Price
- KE $19.17
- SANA $3.16
- Analyst Decision
- KE Buy
- SANA Strong Buy
- Analyst Count
- KE 5
- SANA 4
- Target Price
- KE $22.60
- SANA $13.00
- AVG Volume (30 Days)
- KE 117.3K
- SANA 14.8M
- Earning Date
- KE 02-03-2025
- SANA 02-27-2025
- Dividend Yield
- KE N/A
- SANA N/A
- EPS Growth
- KE N/A
- SANA N/A
- EPS
- KE 0.50
- SANA N/A
- Revenue
- KE $1,650,685,000.00
- SANA N/A
- Revenue This Year
- KE N/A
- SANA N/A
- Revenue Next Year
- KE $3.66
- SANA N/A
- P/E Ratio
- KE $38.30
- SANA N/A
- Revenue Growth
- KE N/A
- SANA N/A
- 52 Week Low
- KE $16.64
- SANA $1.52
- 52 Week High
- KE $25.22
- SANA $12.00
- Technical
- Relative Strength Index (RSI)
- KE 55.89
- SANA 56.84
- Support Level
- KE $17.69
- SANA $3.05
- Resistance Level
- KE $19.20
- SANA $3.86
- Average True Range (ATR)
- KE 0.56
- SANA 0.64
- MACD
- KE 0.08
- SANA 0.18
- Stochastic Oscillator
- KE 80.87
- SANA 28.37
About KE Kimball Electronics Inc.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.